New England Capital Financial Advisors’s Barinthus Biotherapeutics BRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $42 | Hold |
|
|||||
|
2025
Q1 | $44 | Sell |
|
|||||
|
2024
Q4 | $126 | Hold |
|
|||||
|
2024
Q3 | $124 | Hold |
|
|||||
|
2024
Q2 | $146 | Hold |
|
|||||
|
2024
Q1 | $248 | Hold |
|
|||||
|
2023
Q4 | $384 | Hold |
|
|||||
|
2023
Q3 | $322 | Hold |
|
|||||
|
2023
Q2 | $215 | Hold |
|
|||||
|
2023
Q1 | $233 | Hold |
|
|||||
|
2022
Q4 | $282 | Buy |
|